Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2024 Filed Jun 14, 2024 19:40 UTC |
Daniels Eric JosephChief Development Officer
|
PurchaseCommon Stock | 1,431 | $5.29 | $7,569.99 |
DisclosureSEC source: 0001372514-24-000063 · wk-form4_1718394015.xml · nonDerivative · entry 1 Daniels Eric Joseph · CIK 0001892943 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,222 Read SEC document |
| June 13, 2024 Filed Jun 13, 2024 15:51 UTC |
Parsons ErinDirector
|
PurchaseCommon Stock | 5,260 | $4.88 | $25,668.80 |
DisclosureSEC source: 0001372514-24-000061 · wk-form4_1718308256.xml · nonDerivative · entry 1 Parsons Erin · CIK 0001895795 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 5,260 Read SEC document |
| June 13, 2024 Filed Jun 13, 2024 19:49 UTC |
Strem Brian M.Director · President and CEO
|
PurchaseCommon Stock | 3,000 | $5.00 | $14,997.00 |
DisclosureSEC source: 0001372514-24-000060 · wk-form4_1718308174.xml · nonDerivative · entry 1 Strem Brian M. · CIK 0001876429 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,531 Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:49 UTC |
Tosca MelissaEVP Finance
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001372514-23-000150 · wk-form4_1696366139.xml · derivative · entry 2 Tosca Melissa · CIK 0001947184 · EVP Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2033-09-29 F2 · derivative.exercise_date: The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to twenty-five percent (25%) of the shares underlying the Option upon grant on September 29, 2023, twenty-five percent (25%) on September 29, 2024 and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:49 UTC |
Tosca MelissaEVP Finance
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001372514-23-000150 · wk-form4_1696366139.xml · nonDerivative · entry 1 Tosca Melissa · CIK 0001947184 · EVP Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,900 F1 · shares: Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to twenty-five percent (25%) of the shares immediately upon grant, and twenty-five percent (25%) on each of September 29, 2024, September 29, 2025 and September 29, 2026, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 16:43 UTC |
Parsons ErinDirector
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001372514-23-000142 · wk-form4_1696365787.xml · derivative · entry 1 Parsons Erin · CIK 0001895795 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2033-09-29 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:45 UTC |
Stengone Carmine N.Director
|
GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001372514-23-000145 · wk-form4_1696365916.xml · derivative · entry 1 Stengone Carmine N. · CIK 0001861519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2033-09-29 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 16:46 UTC |
Shapiro AronDirector
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001372514-23-000146 · wk-form4_1696365944.xml · derivative · entry 1 Shapiro Aron · CIK 0001855207 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2033-09-29 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 16:44 UTC |
Gayron Kenneth LDirector
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001372514-23-000143 · wk-form4_1696365825.xml · derivative · entry 1 Gayron Kenneth L · CIK 0001669103 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2033-09-29 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 16:46 UTC |
TYLE PRAVEENDirector
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001372514-23-000147 · wk-form4_1696365983.xml · derivative · entry 1 TYLE PRAVEEN · CIK 0001296936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2033-09-29 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:48 UTC |
Daniels Eric JosephChief Development Officer
|
GrantStock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001372514-23-000149 · wk-form4_1696366080.xml · derivative · entry 2 Daniels Eric Joseph · CIK 0001892943 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2033-09-29 F2 · derivative.exercise_date: The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to twenty-five percent (25%) of the shares underlying the Option upon grant on September 29, 2023, twenty-five percent (25%) on September 29, 2024 and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:48 UTC |
Daniels Eric JosephChief Development Officer
|
GrantCommon Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001372514-23-000149 · wk-form4_1696366080.xml · nonDerivative · entry 1 Daniels Eric Joseph · CIK 0001892943 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,338 F1 · shares: Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to twenty-five percent (25%) of the shares immediately upon grant, and twenty-five percent (25%) on each of September 29, 2024, September 29, 2025 and September 29, 2026, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:47 UTC |
Strem Brian M.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001372514-23-000148 · wk-form4_1696366025.xml · derivative · entry 2 Strem Brian M. · CIK 0001876429 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-09-29 F2 · derivative.exercise_date: The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to twenty-five percent (25%) of the shares underlying the Option upon grant on September 29, 2023, twenty-five percent (25%) on September 29, 2024 and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:47 UTC |
Strem Brian M.Director · President and CEO
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001372514-23-000148 · wk-form4_1696366025.xml · nonDerivative · entry 1 Strem Brian M. · CIK 0001876429 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,783 F1 · shares: Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to twenty-five percent (25%) of the shares immediately upon grant, and twenty-five percent (25%) on each of September 29, 2024, September 29, 2025 and September 29, 2026, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:44 UTC |
Hollander DavidDirector
|
GrantStock Option (right to buy) · Derivative | 0 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001372514-23-000144 · wk-form4_1696365864.xml · derivative · entry 1 Hollander David · CIK 0001793796 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2033-09-29 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024. Read SEC document |
| March 03, 2023 Filed Mar 8, 2023 01:15 UTC |
Tosca MelissaEVP Finance
|
GrantStock Option (right to buy) · Derivative | 1,600 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0001372514-23-000036 · wf-form4_167823810655536.xml · derivative · entry 2 Tosca Melissa · CIK 0001947184 · EVP Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 1,600 shares Expires 2033-03-03 F2 · derivative.exercise_date: The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on March 3, 2024, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| March 03, 2023 Filed Mar 8, 2023 01:15 UTC |
Tosca MelissaEVP Finance
|
GrantCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001372514-23-000036 · wf-form4_167823810655536.xml · nonDerivative · entry 1 Tosca Melissa · CIK 0001947184 · EVP Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,400 F1 · shares: Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on each of March 3, 2024, March 3, 2025 and March 3, 2026, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 20:15 UTC |
Parsons ErinDirector
|
GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0001372514-23-000037 · wf-form4_167823812887709.xml · derivative · entry 1 Parsons Erin · CIK 0001895795 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2033-03-03 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 20:14 UTC |
Shapiro AronDirector
|
GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0001372514-23-000032 · wf-form4_167823805057575.xml · derivative · entry 1 Shapiro Aron · CIK 0001855207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2033-03-03 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 20:14 UTC |
Gayron Kenneth LDirector
|
GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0001372514-23-000033 · wf-form4_167823806525564.xml · derivative · entry 1 Gayron Kenneth L · CIK 0001669103 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2033-03-03 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 20:14 UTC |
TYLE PRAVEENDirector
|
GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0001372514-23-000031 · wf-form4_167823803026213.xml · derivative · entry 1 TYLE PRAVEEN · CIK 0001296936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2033-03-03 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 20:13 UTC |
CHANEY PAUL GDirector
|
GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0001372514-23-000029 · wf-form4_167823799654732.xml · derivative · entry 1 CHANEY PAUL G · CIK 0001277477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2033-03-03 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024. Read SEC document |
| March 03, 2023 Filed Mar 8, 2023 01:14 UTC |
Daniels Eric JosephChief Development Officer
|
GrantStock Option (right to buy) · Derivative | 10,400 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0001372514-23-000034 · wf-form4_167823807843002.xml · derivative · entry 2 Daniels Eric Joseph · CIK 0001892943 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,400 Underlying: Common Stock · 10,400 shares Expires 2033-03-03 F2 · derivative.exercise_date: The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on March 3, 2024, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| March 03, 2023 Filed Mar 8, 2023 01:14 UTC |
Daniels Eric JosephChief Development Officer
|
GrantCommon Stock | 15,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001372514-23-000034 · wf-form4_167823807843002.xml · nonDerivative · entry 1 Daniels Eric Joseph · CIK 0001892943 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,838 F1 · shares: Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on each of March 3, 2024, March 3, 2025 and March 3, 2026, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| March 03, 2023 Filed Mar 8, 2023 01:15 UTC |
Strem Brian M.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 10,400 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0001372514-23-000035 · wf-form4_167823809348747.xml · derivative · entry 2 Strem Brian M. · CIK 0001876429 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,400 Underlying: Common Stock · 10,400 shares Expires 2033-03-03 F2 · derivative.exercise_date: The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on March 3, 2024, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| March 03, 2023 Filed Mar 8, 2023 01:15 UTC |
Strem Brian M.Director · President and CEO
|
GrantCommon Stock | 15,600 | $3.83 | $59,748.00 |
DisclosureSEC source: 0001372514-23-000035 · wf-form4_167823809348747.xml · nonDerivative · entry 1 Strem Brian M. · CIK 0001876429 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,783 F1 · shares: Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on each of March 3, 2024, March 3, 2025 and March 3, 2026, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| March 03, 2023 Filed Mar 8, 2023 01:13 UTC |
Hollander DavidDirector
|
GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0001372514-23-000030 · wf-form4_167823801678609.xml · derivative · entry 1 Hollander David · CIK 0001793796 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2033-03-03 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024. Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 21:32 UTC |
Tosca MelissaEVP of Finance
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.78 | $0.00 |
DisclosureSEC source: 0001104659-22-111243 · tm2228925-2_4seq1.xml · derivative · entry 2 Tosca Melissa · CIK 0001947184 · EVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-10-21 F2 · derivative.exercise_date: The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on September 13, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 21:32 UTC |
Tosca MelissaEVP of Finance
|
GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-111243 · tm2228925-2_4seq1.xml · nonDerivative · entry 1 Tosca Melissa · CIK 0001947184 · EVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 F1 · shares: Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on each of September 13, 2023, September 13, 2024 and September 13, 2025, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 21:34 UTC |
Daniels Eric JosephChief Development Officer
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $6.78 | $0.00 |
DisclosureSEC source: 0001104659-22-111246 · tm2228925-3_4seq1.xml · derivative · entry 2 Daniels Eric Joseph · CIK 0001892943 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2032-10-21 F2 · derivative.exercise_date: The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on October 21, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 21:34 UTC |
Daniels Eric JosephChief Development Officer
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-111246 · tm2228925-3_4seq1.xml · nonDerivative · entry 1 Daniels Eric Joseph · CIK 0001892943 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,238 F1 · shares: Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on each of October 21, 2023, October 21, 2024 and October 21, 2025, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 21:30 UTC |
Strem Brian M.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 18,750 | $0.00 Strike: $6.78 | $0.00 |
DisclosureSEC source: 0001104659-22-111239 · tm2228925-1_4seq1.xml · derivative · entry 2 Strem Brian M. · CIK 0001876429 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 18,750 shares Expires 2032-10-21 F2 · derivative.exercise_date: The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on October 21, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 21:30 UTC |
Strem Brian M.Director · President and CEO
|
GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-111239 · tm2228925-1_4seq1.xml · nonDerivative · entry 1 Strem Brian M. · CIK 0001876429 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,183 F1 · shares: Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on each of October 21, 2023, October 21, 2024 and October 21, 2025, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:31 UTC |
Romano SarahChief Financial Officer
|
Tax withholdingCommon Stock | 108 | $0.69 | $74.52 |
DisclosureSEC source: 0001104659-22-020560 · tm226424-1_4seq1.xml · nonDerivative · entry 1 Romano Sarah · CIK 0001697536 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,746 F1 · kind: Sale of shares to cover taxes due on restricted stock that vested on 02/01/2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.69 to $0.70, inclusive. The reporting person hereby undertakes to provide to Kiora Pharmaceuticals, Inc., any security holder of Kiora Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 19:04 UTC |
Parsons ErinDirector
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001104659-22-011494 · tm225348d6_4.xml · derivative · entry 2 Parsons Erin · CIK 0001895795 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-02-01 F2 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 19:04 UTC |
Parsons ErinDirector
|
GrantStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001104659-22-011494 · tm225348d6_4.xml · derivative · entry 1 Parsons Erin · CIK 0001895795 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2032-02-01 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan in connection with the Reporting Person's appointment to the Issuer's Board of Directors. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 19:01 UTC |
Shapiro AronDirector
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001104659-22-011490 · tm225348d1_4.xml · derivative · entry 1 Shapiro Aron · CIK 0001855207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-02-01 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 19:04 UTC |
Gayron Kenneth LDirector
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001104659-22-011495 · tm225348d7_4.xml · derivative · entry 1 Gayron Kenneth L · CIK 0001669103 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-02-01 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 19:06 UTC |
TYLE PRAVEENDirector
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001104659-22-011497 · tm225348d9_4.xml · derivative · entry 1 TYLE PRAVEEN · CIK 0001296936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-02-01 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 19:05 UTC |
CHANEY PAUL GDirector
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001104659-22-011496 · tm225348d8_4.xml · derivative · entry 1 CHANEY PAUL G · CIK 0001277477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-02-01 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 00:06 UTC |
Romano SarahChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001104659-22-011498 · tm225348d10_4.xml · derivative · entry 1 Romano Sarah · CIK 0001697536 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-02-01 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 00:03 UTC |
Daniels Eric JosephChief Development Officer
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001104659-22-011493 · tm225348d4_4.xml · derivative · entry 1 Daniels Eric Joseph · CIK 0001892943 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-02-01 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 00:02 UTC |
Hollander DavidDirector
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001104659-22-011492 · tm225348d3_4.xml · derivative · entry 2 Hollander David · CIK 0001793796 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-02-01 F2 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 00:02 UTC |
Hollander DavidDirector
|
GrantStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001104659-22-011492 · tm225348d3_4.xml · derivative · entry 1 Hollander David · CIK 0001793796 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2032-02-01 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan in connection with the Reporting Person's appointment to the Issuer's Board of Directors. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 00:01 UTC |
Strem Brian M.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001104659-22-011491 · tm225348d2_4.xml · derivative · entry 1 Strem Brian M. · CIK 0001876429 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-02-01 F1 · derivative.exercise_date: The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 22:10 UTC |
FROM STEPHENDirector · Executive Chairman
|
Tax withholdingCommon Stock | 326 | $1.08 | $352.08 |
DisclosureSEC source: 0001104659-22-001942 · tm222161-1_4seq1.xml · nonDerivative · entry 1 FROM STEPHEN · CIK 0001620137 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,693 F1 · kind: Sale of shares to cover taxes due on restricted stock that vested on 01/01/2022. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 22:10 UTC |
Romano SarahChief Financial Officer
|
Tax withholdingCommon Stock | 114 | $1.08 | $123.12 |
DisclosureSEC source: 0001104659-22-001943 · tm222161-2_4seq1.xml · nonDerivative · entry 1 Romano Sarah · CIK 0001697536 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,854 F1 · kind: Sale of shares to cover taxes due on restricted stock that vested on 01/01/2022. Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 21:16 UTC |
FROM STEPHENDirector · Executive Chairman
|
Tax withholdingCommon Stock | 273 | $1.30 | $354.90 |
DisclosureSEC source: 0001104659-21-147638 · tm2134911d2_4seq1.xml · nonDerivative · entry 1 FROM STEPHEN · CIK 0001620137 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,019 F1 · kind: Sale of shares to cover taxes due on restricted stock that vested on 12/01/2021. Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 21:15 UTC |
Romano SarahChief Financial Officer
|
Tax withholdingCommon Stock | 91 | $1.30 | $118.30 |
DisclosureSEC source: 0001104659-21-147635 · tm2134911d1_4seq1.xml · nonDerivative · entry 1 Romano Sarah · CIK 0001697536 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,968 F1 · kind: Sale of shares to cover taxes due on restricted stock that vested on 12/01/2021. Read SEC document |
| November 18, 2021 Filed Nov 22, 2021 21:35 UTC |
Strem Brian M.Director · President and CEO
|
PurchaseCommon Stock | 17,853 | $1.41 | $25,172.73 |
DisclosureSEC source: 0001104659-21-142537 · tm2133588-1_4seq1.xml · nonDerivative · entry 2 Strem Brian M. · CIK 0001876429 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,370 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.395 to $1.41, inclusive. The reporting person hereby undertakes to provide to Kiora Pharmaceuticals, Inc., any security holder of Kiora Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.